125
Participants
Start Date
March 10, 2017
Primary Completion Date
July 30, 2018
Study Completion Date
September 29, 2022
GORE® CARDIOFORM ASD Occluder
Percutaneous Atrial Septal Defect Closure
Mount Sinai Medical Center, New York
Columbia University Medical Center/New York Presbyterian Hospital, New York
Children's Hospital of Philadelphia, Philadelphia
Atrium Health, Charlotte
Children's Healthcare at Egleston, Atlanta
Nicklaus Children's Hospital, Miami
Nationwide Children's Hospital, Columbus
Cleveland Clinic Foundation, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
University of Michigan, Ann Arbor
Children's Hospital of Michigan, Detroit
Mayo Clinic - Rochester, Rochester
Texas Children's Hospital, Houston
The Children's Hospital of Colorado, Aurora
University of Utah, Salt Lake City
Phoenix Children's Hospital, Phoenix
University of California-Los Angeles, Los Angeles
Children's Hospital & Regional Medical Center, Seattle
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Children's Hospital Boston, Boston
W.L.Gore & Associates
INDUSTRY